Francisco Aboitiz is director of the Interdisciplinary Center for Neuroscience and professor of psychiatry at the Pontificia Universidad Católica de Chile. His research lines include the evolution of the brain and cognition and the neurocognitive underpinnings of neuropsychiatric conditions such as attention-deficit/hyperactivity disorder, autism, multiple sclerosis and epilepsy. He is currently working on social projects, including implementing robotics workshops for children in schools of social risk and assessing their cognitive improvements, and screening resilience signatures in adolescent mothers. He has authored more than 140 scientific articles and is author of the books “A Brain for Speech. A View From Evolutionary Neuroanatomy” and “A History of Bodies, Brains and Minds. The Evolution of Life and Consciousness.”
Francisco Aboitiz
Director
Interdisciplinary Center for Neuroscience
From this contributor
Selected articles
- “A multimodal interface for speech perception: the role of the left superior temporal sulcus in social cognition and autism” | Cerebral Cortex
- “Neural responses to sensory novelty with and without conscious access” | Neuroimage
- “The Enigmatic Reissner's Fiber and the Origin of Chordates ” | Frontiers in Neuroanatomy
- “Neurocognitive mechanisms underlying working memory encoding and retrieval in Attention-Deficit/Hyperactivity Disorder” | Scientific Reports
- “Origin and evolution of human speech: Emergence from a trimodal auditory, visual and vocal network” | Progress in Brain Research
- “Morphological evolution of the vertebrate forebrain: From mechanical to cellular processes” | Evolution & Development
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.